NMI Software
510(k) K950270
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK950270 | Date15 May 1995 | StatusActive |
Recalls
No FDA recalls found in the data synced 5 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- OMB
- Device Class
- Class II
- Regulation
- 21 CFR Part 882.1400
- Advisory Committee
- Neurology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
NMI Software is an Automatic Event Detection Software designed for full-montage electroencephalograph (EEG) systems. It processes EEG recordings to identify and flag epileptiform events, aiding neurologists in the detection and analysis of abnormal brain wave patterns. The software operates within the framework of EEG monitoring, assisting in the interpretation of neurological activity for diagnostic purposes.
This software is supplied as part of an integrated EEG system and is intended for use in clinical settings by trained professionals. It is classified as a Class II medical device under FDA regulations (21 CFR 882.1400) and has received FDA 510(k) clearance (K950270) as substantially equivalent to a predicate device. The software is not described as single-use or reusable, nor is there mention of sterility or MRI compatibility in the available data. It is regulated under the OMB product code and is associated with the Neurology advisory committee.
Other devices from Nicolet Biomedical, Inc.
Questions
AI-generated answers, 1 Oct 2026
What is the NMI Software designed to do within an EEG system?
The NMI Software is an Automatic Event Detection Software integrated into full-montage electroencephalograph (EEG) systems. It processes EEG recordings to identify and flag epileptiform events—abnormal brain wave patterns—helping neurologists detect and analyze these events more efficiently. This assists in diagnosing neurological conditions by streamlining the interpretation of EEG data.
Who is this software intended for, and where is it used?
The NMI Software is intended for use in clinical settings by trained professionals, specifically neurologists or EEG technicians. It is designed to support diagnostic workflows by enhancing the detection of epileptiform activity during EEG monitoring. The software is part of an integrated EEG system and is not standalone.
Is the NMI Software single-use or reusable, and what about sterility?
The available data does not specify whether the NMI Software is single-use or reusable. Since it is a software component of an EEG system, its usability depends on the system’s hardware and maintenance protocols. There is no mention of sterility requirements, as software itself is not subject to sterility standards like physical medical devices.
What regulatory pathway does the NMI Software follow?
The NMI Software is classified as a Class II medical device under FDA regulations (21 CFR 882.1400) and has received FDA 510(k) clearance (K950270). This clearance confirms it is substantially equivalent to a predicate device, meaning it meets the same performance standards as an existing approved product. The software is regulated under the OMB product code and reviewed by the Neurology Advisory Committee.
Can this software be used with any EEG system, or is it specific to Nicolet’s hardware?
The NMI Software is supplied as part of an integrated EEG system developed by Nicolet Biomedical, Inc. While the data does not explicitly state compatibility with non-Nicolet systems, its design suggests it is tailored for use within Nicolet’s EEG platforms. Clinicians should verify system compatibility with their specific hardware before implementation.